Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Japan Lifeline CoFRA:L8B +1.39%84 PB Ratio is 1.43 as of Jul. 15, 2026, which is 31% below its 10-year median of 2.07. GuruFocus rates FRA:L8B with a GF Score™ of 84/100 and a GF Value™ of €8.11. Among 787 Medical Devices & Instruments companies, Japan Lifeline Co ranks better than 65.82% on this metric.
Japan Lifeline Co Ltd stock PB Ratio (=1.45) is close to 3-year low of 1.34.
The historical rank and industry rank for Japan Lifeline Co's PB Ratio or its related term are showing as below:
FRA:L8B'
s PB Ratio Range Over the Past 10 Years
Min: 1.24 Med: 2.07 Max: 10.54
Current: 1.47
During the past 13 years, Japan Lifeline Co's highest PB Ratio was 10.54. The lowest was 1.24. And the median was 2.07.
FRA:L8B's PB Ratio is ranked better than 65.82% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs FRA:L8B: 1.47
During the past 12 months, Japan Lifeline Co's average Book Value Per Share Growth Rate was 9.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 9.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 8.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 13.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Japan Lifeline Co was 42.10% per year. The lowest was -0.40% per year. And the median was 3.40% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Japan Lifeline Co PB Ratio Related Terms
Japan Lifeline Co PB Ratio Historical Data
* Premium members only.
The historical data trend for Japan Lifeline Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Japan Lifeline Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Japan Lifeline Co PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Japan Lifeline Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Japan Lifeline Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Japan Lifeline Co (FRA:L8B) has a PB Ratio of 1.43 as of Jul. 15, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Japan Lifeline Co and its competitors. This is 31% below median its historical median of 2.07. Over the past decade, Japan Lifeline Co's PB Ratio has ranged from 1.24 to 10.54. According to the industry distribution chart, Japan Lifeline Co ranks #269 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 34.2%.
Is Japan Lifeline Co's PB Ratio too high?
Japan Lifeline Co's current PB Ratio of 1.43 is 31% below median its 10-year median of 2.07. Over the past 10 years, this metric has ranged from a low of 1.24 to a high of 10.54. The Medical Devices & Instruments industry median PB Ratio is 2.05. Japan Lifeline Co's value of 1.43 is 30.2% below this industry median. Based on the distribution chart, Japan Lifeline Co ranks #269 out of 787 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Japan Lifeline Co has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Japan Lifeline Co's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Japan Lifeline Co ranks #269 out of 787 companies for PB Ratio. This puts Japan Lifeline Co in the upper half of its industry. The industry median PB Ratio is 2.05. Japan Lifeline Co's value of 1.43 is 30.2% below this benchmark. Historically, Japan Lifeline Co's own PB Ratio has ranged from 1.24 to 10.54 over the past decade. While the company's 10-year median is 2.07 vs. the industry median of 2.05, Japan Lifeline Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.05, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Japan Lifeline Co's current PB Ratio of 1.43 is 30.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Japan Lifeline Co and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Japan Lifeline Co's current PB Ratio is 1.43, which is 31% below median its own 10-year median of 2.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Lifeline Co stock overvalued right now?
Japan Lifeline Co (FRA:L8B) has a current PB Ratio of 1.43. The stock's GF Value™ is €8.11, compared to a current price of €7.30 — trading 10% below its estimated fair value. The current PB Ratio is 1.43, which is 31% below median its 10-year median of 2.07 and 30.2% below the Medical Devices & Instruments industry median of 2.05. Japan Lifeline Co's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Japan Lifeline Co (FRA:L8B), the current PB Ratio is 1.43 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Japan Lifeline Co (FRA:L8B) Overvalued in 2026?
Based on GuruFocus' analysis, Japan Lifeline Co stock appears to be undervalued.
The current stock price of €7.30 is trading 10% below its estimated GF Value™ of €8.11.
Key valuation signals for FRA:L8B:
PB Ratio: 1.43 (31% below median its 10-year median of 2.07)
GF Value™: €8.11 vs. price of €7.30 (10% below fair value)
Industry Position: 30.2% below the Medical Devices & Instruments median (#269 of 787)
No single metric tells the full story. See the FRA:L8B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Japan Lifeline Co Ltd is a medical device company operating in Japan. It is engaged in the trading and manufacturing of medical devices specialized in the cardiovascular field. The company offers medical devices mainly for the treatment of cardiac and vascular diseases. It focuses on providing implantable devices to treat arrhythmias; disposable catheter devices with electrodes for diagnosis and treatment of arrhythmias; prosthetic devices to replace blood vessels and heart valves that lost their functions; and devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities and congenital cardiac diseases.
84GF Score
Get the complete analysis for FRA:L8B
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L8B has been successfully added to your 
